NCT06962189
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
Not specified
Clinical trial condition
Lung Neoplasms
Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.
4,219 public trials
1,011 recruiting studies
Lung Neoplasms trial results
Not Yet Recruiting
Nano-crystalline Megestrol Acetate Combined With Standard Treatment Versus Standard Treatment for First-line Extensive-stage Small Cell Lung Cancer in the Cachexia Phase
NCT06961201
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small Cell Lung Cancer (ES-SCLC), +9 more
- Locations
-
- West China School of Medicine/West China Hospital of Sichuan University Chengdu, Sichuan, China
Not Yet Recruiting
Umbrella Trial of Adjuvant Therapy in Completely Resected High-risk Stage IA-IB NSCLC: Focus on Driver Mutations
NCT06955325
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
Not specified
NCT06951841
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
- Locations
-
- The First Affiliated Hospital of China Medical University Shenyang, Liaoning, China
NCT06914050
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Limited-stage Small Cell Lung Cancer (LS-SCLC), +9 more
- Locations
-
Not specified
Not Yet Recruiting
Benmelstobart, Anlotinib and Chemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer
NCT06931145
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small Cell Lung Cancer, +8 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
Not Yet Recruiting
Evaluate Safety and Tolerability of RX001 in Patients With KRAS Mutant Advanced NSCLC
NCT06934590
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Konkuk University Medical Center Seoul, South Korea
Not Yet Recruiting
SHR0302 Combined With PD-1/PD-L1 Inhibition for Treatment naïve or Acquired Resistant to Immunology NSCLC
NCT06925048
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
Not specified
Not Yet Recruiting
XP-102 and XP-102 in Combination With Trametinib in Advanced Solid Tumor Patients With a BRAF V600 Mutation
NCT05275374
- Conditions
- BRAF V600 Mutation, Bronchial Neoplasms, Cancer, +36 more
- Locations
-
Not specified
Not Yet Recruiting
Integrating Surgery and Radiotherapy Following Tislelizumab-based Conversion Therapy in N3-Stage III NSCLC
NCT06908733
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
Not specified